1. 2023
  2. Local irradiation of patient-derived tumors in immunodeficient mice

    van der Zalm, A. P., Bootsma, S., Rodermond, H. M., Oei, A. L. & Bijlsma, M. F., 17 Mar 2023, In: STAR Protocols. 4, 1, 102098.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2022
  4. FOXO transcriptional activity is associated with response to chemoradiation in EAC

    Creemers, A., van der Zalm, A. P., van de Stolpe, A., Holtzer, L., Stoffels, M., Hooijer, G. K. J., Ebbing, E. A., van Ooijen, H., van Brussel, A. G. C., Aussems-Custers, E. M. G., van Berge Henegouwen, M. I., Hulshof, M. C. C. M., Bergman, J. J. G. H. M., Meijer, S. L., Bijlsma, M. F. & van Laarhoven, H. W. M., 1 Dec 2022, In: Journal of translational medicine. 20, 1, 183.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer

    Dings, M. P. G., van der Zalm, A. P., Bootsma, S., van Maanen, T. F. J., Waasdorp, C., van den Ende, T., Liu, D., Bailey, P., Koster, J., Zwijnenburg, D. A., Spek, C. A., Klomp, J. P. G., Oubrie, A., Hooijer, G. K. J., Meijer, S. L., van Berge Henegouwen, M. I., Hulshof, M. C., Bergman, J., Oyarce, C., Medema, J. P., & 2 othersvan Laarhoven, H. W. M. & Bijlsma, M. F., 15 Nov 2022, In: Cell Reports Medicine. 3, 11, 100802.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. 2021
  7. 2020
  8. 2019
  9. Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma

    Steins, A., Ebbing, E. A., Creemers, A., van der Zalm, A. P., Jibodh, R. A., Waasdorp, C., Meijer, S. L., van Delden, O. M., Krishnadath, K. K., Hulshof, M. C. C. M., Bennink, R. J., Punt, C. J. A., Medema, J. P., Bijlsma, M. F. & van Laarhoven, H. W. M., 2019, In: International journal of cancer. Journal international du cancer. 145, 10, p. 2792-2803

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma

    Ebbing, E. A., van der Zalm, A. P., Steins, A., Creemers, A., Hermsen, S., Rentenaar, R., Klein, M., Waasdorp, C., Hooijer, G. K. J., Meijer, S. L., Krishnadath, K. K., Punt, C. J. A., van Berge Henegouwen, M. I., Gisbertz, S. S., van Delden, O. M., Hulshof, M. C. C. M., Medema, J. P., van Laarhoven, H. W. M. & Bijlsma, M. F., 2019, In: Proceedings of the National Academy of Sciences of the United States of America. 116, 6, p. 2237-2242

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 4522116